Determination of Health Care Needs of Elderly Individuals According to the Omaha Classification System and Investigation of the Effects of Implemented Nursing Interventions on Healthy Lifestyle Behaviors and Quality of Life
Launched by NAZMIYE GÜNEY · Mar 9, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the health care needs of elderly individuals and how nursing support can help improve their quality of life and promote healthy lifestyle choices. Researchers are using a method called the Omaha Classification System to systematically assess what elderly patients need in terms of health care. By providing tailored nursing interventions based on these needs, the study aims to ensure that elderly individuals receive continuous care and support.
To participate in this trial, individuals must be 65 years or older and able to care for themselves. Unfortunately, those who have communication difficulties or mental impairments will not be eligible to join. Participants can expect to receive personalized nursing care and support throughout the study, which is designed to help them maintain their health and improve their overall well-being. This trial is currently looking for participants, and it hopes to make a positive impact on the lives of elderly people in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 65 years old self care
- Exclusion Criteria:
- • comminication barrier mentally handicapped
About Nazmiye Güney
Nazmiye Güney is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a commitment to ethical standards and rigorous scientific methodologies, the organization collaborates with healthcare professionals, researchers, and regulatory bodies to design, implement, and oversee clinical trials across various therapeutic areas. Nazmiye Güney prioritizes transparency, safety, and efficacy in all its endeavors, striving to contribute valuable insights to the medical community and enhance treatment options for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Famagusta, Mutluyaka, Cyprus
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials